Notice

Decision on introduction of ACPi product to Iran, and application for KFDA

Decision on introduction of ACPi product, Iran, consultation on MOH (Iran Food and Drug Administration) registration procedure, and ACPi manual, application for domestic Food and Drug Administration certification

P Company, an Iranian partner who decided to introduce CSTD for anticancer drug preparation, decided to introduce ACPi with ACPi and AACPi technology competitiveness, and has requested CE, PMDA (Japanese certification), and FDA certification.

Manual is the same as the Anyfusion pump, and responds to the domestic and CE certification status so that it can be exported quickly.

This contract is intended to be concluded after domestic certification.

Many hospitals where ACPi has been introduced in Korea are also considering the purchase of manual ACPI due to the difficulty of the anticancer drug preparation environment.

We would like to request a sufficient performance test to the company and an authorized institution before permission.

Medical institutions in Seoul and the metropolitan area are requesting reliable performance test data from accredited institutions, and these data will be helpful for the sales of ACPi.


Thank you.

Next Decision to register two patents for ACPi and second cylinder pump
Prev Concluded consulting CDA for entering the Japanese market with two Japanese companies